Company Overview of Medarex, Inc.
Medarex, Inc. engages in the discovery, development, and commercialization of human antibody-based therapeutics for the treatment of cancer, inflammation, autoimmune disorders, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. It has research facilities in Milpitas and Sunnyvale, California; a research and development facility in Greenwich Township, New Jersey; and a manufacturing facility in Annandale, New Jersey. As of August 31, 2009, Medarex, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
707 State Road
Princeton, NJ 08540-1437
Founded in 1987
Key Executives for Medarex, Inc.
Similar Private Companies By Industry
|Alector LLC||United States|
|Evolutionary Genomics, Inc. and EG I, LLC||United States|
|Medicinal Genomics Corporation||United States|
|Stemcell Global Research, Inc.||United States|
|Lundbeck Research USA, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Medarex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.